Institutions of higher learning are working hard to provide effective, high quality educational programs. Meanwhile, potential students are also looking at “quality” as a metric to help make their decisions about which college to join. Mechanisms to evaluate the quality of higher education offered in universities are already available. This study aimed to determine students’ attitudes and opinions regarding the pharmacy curriculum at the International Islamic University Malaysia (IIUM). A survey instrument was administered to all final year bachelor of pharmacy (BPharm) students. Forty students (93%) completed and returned the survey. The majority of students (75%) expressed their satisfaction regarding the curriculum in general. Most students (74%) were also satisfied with the courses offered by the department of pharmacy practice. However, students were not satisfied with certain issues such as overlapping of some pharmacy practice courses, and the inclusion of the Malaysian language course in the BPharm curriculum.
Hypertension is a prevalent chronic disease, which is strongly related to the development of cerebrovascular and cardiovascular diseases. The prevalence of hypertension in Malaysia in subjects aged 15 years and above was estimated to be 27.8%. Cost-effectiveness analysis (CEA) compares treatment options with different effectiveness and safety profiles. The utilisation of antihypertensive drugs has raised some concerns about the balance between its costs and benefits. This study was conducted to describe the healthcare costs for hypertensive subjects and to examine the cost-effectiveness of different classes of antihypertensive drugs used in Malaysia. Retrospective and prospective data analysis of a cohort of uncomplicated hypertensive patients was conducted to determine ambulatory health care costs among hypertensive patients groups. The total direct and
indirect costs of controlled and uncontrolled blood pressure (BP) were described. The health care
costs ($) / clinical outcome (AC/E ratio) was calculated. Mean total direct costs per patient per month was higher in uncontrolled blood pressure groups compared to the controlled blood pressure groups. The cost-effectiveness relationship was more favourable for diuretics (1.9), angiotensin converting enzyme inhibitors (ACEIs) (2.0), prazosin (2.4) and beta blockers (2.5), more than the diuretics and beta blockers combination theraphy (3.0), calcium channel blockers (CCBs) (3.4) and other combinations (6.1). Antihypertensive drugs used to treat hypertensive patients were different
in their cost-effectiveness ratios. Such results will allow health care professionals and/or decision
makers to make better decisions on how to select treatment options for hypertensive patients in
Malaysia and how to distribute and allocate scarce health care resources. Pharmacoeconomic
evaluations can help in making difficult choices rationally and allocate scarce resources efficiently.